I36M (p.Ile36Met) variant of KRAS (GTPase KRas)

I36M (p.Ile36Met) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of RASopathy; KRAS-related disorder; Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.78 / 1. The record also includes experimental measurements, published literature, and structural context.

I36M (p.Ile36Met) variant details